VNS - Vitaria
Device Cardiology/Vascular Diseases
General payments
$382,506
Research payments
$4,947,986
Through program year 2023, $382,506 in general payments and $4,947,986 in research payments were reported against VNS - Vitaria (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $67,911 | 95 |
| 2023 | Research | $1,114,087 | 228 |
| 2022 | General | $176,689 | 188 |
| 2022 | Research | $2,182,051 | 351 |
| 2021 | General | $137,906 | 194 |
| 2021 | Research | $1,651,847 | 504 |
Breakdown
The top 5 of 26 recipients; each share is of general payments naming this product in 2023.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
477 general · 1,083 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.